Rabin Medical Center is a major hospital and medical center located in Petah Tikva, Israel. It is owned and operated by Clalit Health Services, Israel's largest health maintenance organization. In January 1996, Beilinson Hospital and Hasharon Hospital were merged and renamed Rabin Medical Center.

During the past decade, Department of Otolaryngology, Rabin Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Otolaryngology, Rabin Medical Center" are "Nasopharyngeal Carcinoma" (1 trials) and "Surgical Wound Infection" (1 trials). Many other conditions were trialed in "Department of Otolaryngology, Rabin Medical Center" in a lesser frequency.

Most popular intervention types in "Department of Otolaryngology, Rabin Medical Center" are "Drug" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cefazolin" (1 trials), "Chemoradiotherapy for nasopharyngeal carcinoma" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Otolaryngology, Rabin Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department of Otolaryngology, Rabin Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Department of Otolaryngology, Rabin Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Otolaryngology, Rabin Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".